We count visits as totals without cookies, and never follow you from one day to the next. If you accept, we also use cookies to see how people use this site, so we can improve it. Privacy policy
Foreign stocks · NASDAQ · Healthcare · Medical devices
Held by 10 funds10 open to buy5 AMCs
Last close (USD)468.52−13.58 (−2.82%)as of 5 Nov 2026
Funds that hold it10One fund per scheme
Held through a master fund100 buy the stock themselves
Largest weight in a single fund14.72%Of that fund's NAV
Median weight2.91%Half the funds hold more than this
What does ISRG do
Intuitive Surgical, Inc.
Makes the da Vinci surgical robot that hospitals use for minimally invasive surgery. Most revenue comes from instruments and consumables that must be bought for every procedure, not just the machine itself
da Vinci Surgical SystemIonSurgical equipment and instruments
Where the revenue comes from, and how much is left as profit (FY2025)
For every 100 dollars of sales: cost of sales 34 · operating expenses 37 · tax and other items 1 · leaving 28 as net profit
Which funds let you invest in ISRG
Sorted by weight held, largest first
Investors in Thailand can buy ISRG through 10 mutual funds open to retail investors. Most of them (10 funds) don't buy the stock themselves. Instead they invest in a master fund abroad, which in turn holds ISRG.
The many funds holding less than 3% are usually index funds holding at market weight · Funds holding more than 8% have deliberately chosen a large position
How many funds each AMC holds it through
UOBAM
How Thai money reaches ISRG
6 master funds
Master fund
Thai funds using this route
Master fund's ISRG weight
United Global Healthcare Fund
3
2.92%
Wellington Global Health Care Equity Fund
3
2.39%
iShares U.S. Medical Devices ETF
1
14.72%
Global X Robotics & Artificial Intelligence ETF
1
8.65%
Data sourcesFunds that buy the stock themselves: top 5 holdings from the AMC's fact sheet as of 30 Sep 2026 · Funds that invest through a master fund: the master fund's portfolio from its issuer's fact sheet or prospectus · Each scheme counts as one fund · Share price: Market data · Financial statements: SEC EDGAR · Ratios: Market data · Revenue by business segment: SEC EDGAR · Weights are as of the report date, and funds can change their portfolios at any time · Investing involves risk. This is not investment advice.
Showing 10 of 10 funds you can buy · The full list is in the Expert view · Latest weights from portfolio reports, and funds can change their portfolios at any time · Past performance is not a guarantee of future performance
SSF
Holds ISRG 2.37%
Valuation and key ratios
Intuitive Surgical, Inc. · NASDAQ · Fiscal year ends in January
Market cap165.4B USD0.35 billion shares
P/E59.5xPrice ÷ FY2025 EPS 7.87
Forward P/E39.7xBased on forecast 12-month earnings
P/S14.9x
EV/EBITDA36.4x
Dividend yield0.00%0.00 USD per share a year
ROE16.7%Net profit ÷ shareholders' equity
Debt to equity (D/E)0.00xInterest-bearing debt
Beta1.40Against the S&P 500
Gross margin66.0%FY2025
Operating margin29.3%FY2025
Net margin28.4%FY2025
Price ratios use the latest close shown on this page · Forward P/E, P/S and EV/EBITDA from Market data · Beta from 5 years of monthly returns · Total dividends over the last 12 months
Company health made simple
From the FY2025 statements
Sales growth15.2%Fast growth
Yearly average over the last 4 years · Latest annual sales 10.1B USD
Profit from sales28%Highly profitable
For every 100 dollars of sales, about 28 dollars is left as net profit
Dividend0.00%No dividend
Per year, relative to the share price · Tech stocks tend to pay little because they reinvest their profits
1-year share price−14.6%Down
Now 21.0% below its 1-year high
A rise or fall in the share price doesn't move a fund by the same amount — a fund is affected only in proportion to how much it holds
Financial statements
Revenue grows 15.2% a year on average · EPS grows 14.0% a year on average
Annual · last 5 fiscal years
Revenue and net profit
FY20215.7B USD1.7B USD
FY20226.2B USD1.3B USD
FY20237.1B USD1.8B USD
FY20248.4B USD2.3B USD
FY202510.1B USD2.9B USD
Total revenue
Net profit
Quarterly · last 5 quarters
Revenue and net profit
Q2 FY20252.4B USD658.0M USD
Q3 FY20252.5B USD704.0M USD
Q4 FY20252.9B USD795.0M USD
Q1 FY20262.8B USD822.0M USD
Q2 FY20262.9B USD818.0M USD
Annual income statement, balance sheet and cash flow
Item (USD)
FY2021
FY2022
FY2023
FY2024
FY2025
Total revenue
5.7B USD
6.2B USD
7.1B USD
8.4B USD
10.1B USD
Gross profit
4.0B USD
4.2B USD
4.7B USD
5.6B USD
6.6B USD
Operating profit
Free cash flow = operating cash flow − capital expenditure · A cell showing N/A is an item the statement doesn't report, not a zero · Source: SEC EDGAR
Technical analysis
Closed at 468.52 USD on 5 Nov 2026
Daily trendClear uptrendScore 1.00 on a scale of −1 to +1 · 1254 bars
RSI(14)
64.8
ADX(14)
31.3
Position in the price range
90%
Weekly trendClear uptrendScore 0.90 on a scale of −1 to +1 · 261 bars
RSI(14)
60.6
ADX(14)
22.7
Position in the price range
52%
Monthly trendLeaning upScore 0.33 on a scale of −1 to +1 · 61 bars
RSI(14)
52.4
ADX(14)
19.1
Position in the price range
58%
Moving averages (daily)
Period
SMA
EMA
Price vs line
10 days
450.30
450.93
Above
20 days
439.73
439.92
Above
50 days
408.22
419.70
Above
100 days
397.01
415.01
Above
200 days
Indicators (daily)
Indicator
Value
Signal
RSI(14)
64.82
Up
MACD(12,26)
14.14
Up
ADX(14)
31.31
Neutral
ATR(14) % of price
1.94
Neutral
Support and resistance (weekly pivots)
s3405
s2418
s1
Trend score = average of the moving-average group and the indicator group ((up signals − down signals) ÷ number of signals) · RSI and ATR use Wilder's method · MACD uses the 12- and 26-period EMA · An ADX of 25 or above counts as a clear trend · Calculated from daily closing prices from Market data · Not investment advice
One fund counted per scheme · Funds investing through a master fund show the master fund's weight in ISRG, not the look-through weight · Past performance is not a guarantee of future performance
ONE-MEDTECHONE MEDICAL TECHNOLOGY FUND
UBOTUnited Robotics & Artificial Intelligence ETF
SCBIHEALT(SSFE)SCB Healthcare Innovation
TGHDIGITISCO Global Digital Health Equity Fund
BCARERMFBualuang Global Health Care RMF